Trial Phase
Trial Status
Paid Participation
Clear All
33 Cholangiocarcinoma Trials Near You
Power is an online platform that helps thousands of Cholangiocarcinoma patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerNivolumab + Ipilimumab for Rare Cancers
Trial Details
Key Eligibility Criteria
818 Participants Needed
Chemotherapy for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
452 Participants Needed
Pevonedistat + Chemotherapy for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
40 Participants Needed
Entrectinib for Solid Tumors
Trial Details
Key Eligibility Criteria
534 Participants Needed
Chemotherapy + Binimetinib for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
66 Participants Needed
MK-7684A for Advanced Cancers
Trial Details
Key Eligibility Criteria
613 Participants Needed
TC-510 Cell Therapy for Cancer
Trial Details
Key Eligibility Criteria
6 Participants Needed
NGM831 + Pembrolizumab for Cancer
Trial Details
Key Eligibility Criteria
130 Participants Needed
Durvalumab + Chemotherapy for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
27 Participants Needed
Olaparib for Advanced Cancer
Trial Details
Key Eligibility Criteria
145 Participants Needed
AZD5305 for Advanced Cancers
Trial Details
Key Eligibility Criteria
804 Participants Needed
Pembrolizumab + Chemotherapy for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
1069 Participants Needed
LY4066434 for Solid Tumors
Trial Details
Key Eligibility Criteria
750 Participants Needed
IDE397 for Solid Tumors
Trial Details
Key Eligibility Criteria
180 Participants Needed
DB-1303 for Solid Cancers
Trial Details
Key Eligibility Criteria
766 Participants Needed
Regorafenib + Durvalumab for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
40 Participants Needed
LSTA1 + Standard Care for Advanced Cancers
Trial Details
Key Eligibility Criteria
80 Participants Needed
Sacituzumab Govitecan for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
22 Participants Needed
SynKIR-110 for Ovarian Cancer
Trial Details
Key Eligibility Criteria
42 Participants Needed
Pemigatinib vs Chemotherapy for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
167 Participants Needed
Zanidatamab + Standard Therapy for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
286 Participants Needed
Rilvegostomig + Chemotherapy for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
750 Participants Needed
VAXINIA + Pembrolizumab for Cancer
Trial Details
Key Eligibility Criteria
100 Participants Needed
NGM707 + Pembrolizumab for Cancer
Trial Details
Key Eligibility Criteria
179 Participants Needed
Zanidatamab + Chemotherapy for Gastrointestinal Cancers
Trial Details
Key Eligibility Criteria
74 Participants Needed
Tucatinib + Trastuzumab for HER2-Positive Cancers
Trial Details
Key Eligibility Criteria
217 Participants Needed
CTX-009 + Paclitaxel for Biliary Tract Cancer
Trial Details
Key Eligibility Criteria
150 Participants Needed
Tinengotinib for Bile Duct Cancer
Trial Details
Key Eligibility Criteria
200 Participants Needed
Chemotherapy + Atezolizumab for Advanced Liver Cancer
Trial Details
Key Eligibility Criteria
88 Participants Needed
AMG 193 + Docetaxel for Advanced Solid Cancers
Trial Details
Key Eligibility Criteria
649 Participants Needed
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.